NEK2 is a potential pan-cancer biomarker and immunotherapy target

NEK2 is a potential pan-cancer biomarker and immunotherapy target

Abstract Background NEK2 is a member of the NEKs family and plays an important role in cell mitosis. Increasing evidence suggests that NEK2 is associated with the development of multiple tumors, but systematic studies of NEK2 in cancer are still lacking. Therefore, we evaluated the prognostic value...

Full description

Saved in:
Bibliographic Details
Main Authors: Lanyue Zhang, Yang Li, Juexiao Deng, Wenxin Liao, Tingting Liu, Fujin Shen
Format: Article
Language:English
Published: Springer 2024-11-01
Series:Discover Oncology
Subjects:
NEK2
Pan-cancers
Diagnosis
Prognosis
Tumor immunity
Online Access:https://doi.org/10.1007/s12672-024-01519-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items